Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment
Vincenzo Salpietro,Nancy T. Malintan,Isabel Llano-Rivas,Christine G. Spaeth,Stephanie Efthymiou,Pasquale Striano,Jana Vandrovcova,Maria C. Cutrupi,Roberto Chimenz,Emanuele David,Gabriella Di Rosa,Anna Marce-Grau,Miquel Raspall-Chaure,Elena Martin-Hernandez,Federico Zara,Carlo Minetti,Vincenzo Salpietro,Stephanie Efthymiou,Yamna Kriouile,Mohamed El Khorassani,Mhammed Aguennouz,Blagovesta Karashova,Daniela Avdjieva,Hadil Kathom,Radka Tincheva,Lionel Van Maldergem,Wolfgang Nachbauer,Sylvia Boesch,Larissa Arning,Dagmar Timmann,Bru Cormand,Belen Pérez-Dueñas,Gabriella Di Rosa,Erica Pironti,Jatinder S. Goraya,Tipu Sultan,Salman Kirmani,Shahnaz Ibrahim,Farida Jan,Jun Mine,Selina Banu,Pierangelo Veggiotti,Michel D. Ferrari,Alberto Verrotti,Gian Luigi Marseglia,Salvatore Savasta,Barbara Garavaglia,Carmela Scuderi,Eugenia Borgione,Valeria Dipasquale,Maria Concetta Cutrupi,Simona Portaro,Benigno Monteagudo Sanchez,Mercedes Pineda-Marfa’,Francina Munell,Alfons Macaya,Richard Boles,Gali Heimer,Savvas Papacostas,Andreea Manole,Nancy Malintan,Maria Natalia Zanetti,Michael G. Hanna,James E. Rothman,Dimitri M. Kullmann,Henry Houlden,Oscar D. Bello,Rita De Zorzi,Sara Fortuna,Andrew Dauber,Mariam Alkhawaja,Tipu Sultan,Kshitij Mankad,Antonio Vitobello,Quentin Thomas,Frederic Tran Mau-Them,Laurence Faivre,Francisco Martinez-Azorin,Carlos E. Prada,Alfons Macaya,Dimitri M. Kullmann,James E. Rothman,Shyam S. Krishnakumar,Henry Houlden
DOI: https://doi.org/10.1016/j.ajhg.2019.02.016
2019-04-01
The American Journal of Human Genetics
Abstract:VAMP2 encodes the vesicular SNARE protein VAMP2 (also called synaptobrevin-2). Together with its partners syntaxin-1A and synaptosomal-associated protein 25 (SNAP25), VAMP2 mediates fusion of synaptic vesicles to release neurotransmitters. VAMP2 is essential for vesicular exocytosis and activity-dependent neurotransmitter release. Here, we report five heterozygous de novo mutations in VAMP2 in unrelated individuals presenting with a neurodevelopmental disorder characterized by axial hypotonia (which had been present since birth), intellectual disability, and autistic features. In total, we identified two single-amino-acid deletions and three non-synonymous variants affecting conserved residues within the C terminus of the VAMP2 SNARE motif. Affected individuals carrying de novo non-synonymous variants involving the C-terminal region presented a more severe phenotype with additional neurological features, including central visual impairment, hyperkinetic movement disorder, and epilepsy or electroencephalography abnormalities. Reconstituted fusion involving a lipid-mixing assay indicated impairment in vesicle fusion as one of the possible associated disease mechanisms. The genetic synaptopathy caused by VAMP2 de novo mutations highlights the key roles of this gene in human brain development and function.
genetics & heredity